Open AccessBaseline tubular biomarkers in young adults with congenital heart disease as compared to healthy young adults: Detecting subclinical kidney injury
Author(s) -
Fuhrman Dana Y.,
Nguyen Lan,
Hindes Morgan,
Kellum John A.
Publication year - 2019
Publication title -
congenital heart disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.828
H-Index - 42
eISSN - 1747-0803
pISSN - 1747-079X
DOI - 10.1111/chd.12862
Subject(s) - medicine , subclinical infection , kidney disease , kidney , renal function , heart disease , urinary system , creatinine , proteinuria , biomarker , gastroenterology , endocrinology , biochemistry , chemistry
Background There are significant implications for kidney disease in young adults with congenital heart disease. Prior investigations have not focused on the use of urinary tubular biomarkers for the early identification of kidney disease in this growing patient group. Objective Determine if young adults with congenital heart disease have differences in the baseline concentration of urinary tubular biomarkers when compared to healthy young adults. Design/Methods In a pilot case control study, 30 patients from 18 to 35 years of age with congenital heart disease and a normal serum creatinine were recruited during a routine follow‐up visit. In the same age group, 30 control subjects without history of heart or kidney disease were recruited. Urine samples were obtained to measure beta 2‐microglobin, alpha 1‐microglobin, N‐acetyl‐B‐D‐glucosaminidase, liver fatty acid binding protein, kidney injury molecule‐1, insulin‐like growth factor binding protein 7, and tissue inhibitor of metalloproteinases‐2. Comparisons were done using Wilcoxon rank‐sum or Fisher’s exact test. Results No study participants had proteinuria on urine dipstick. Median concentrations of kidney injury molecule‐1 were higher ( P = .01) and concentrations of insulin‐like growth factor binding protein 7 ( P = .001) and tissue inhibitor of metalloproteinases‐2 ( P = .009) were lower in the subjects with congenital heart disease when compared to the control subjects. There were no significant differences between the groups with respect to the other biomarkers. Conclusion Our data suggest that young adults with congenital heart disease may have subclinical kidney dysfunction. Lower levels of insulin‐like growth factor binding protein 7 and tissue inhibitor of metalloproteinases‐2 may indicate an impaired ability to respond to injury, while higher levels of kidney injury molecule‐1 may reflect early tubular injury.